[ET Net News Agency, 23 November 2020] CSPC Pharmaceutical Group Limited (01093) said
its profit attributable to shareholders was RMB3.52 billion for the nine months ended 30
September 2020, a year-on-year increase of 25.1%. The basic earnings per share were
RMB29.43 cents.
The total revenue was RMB19.22 billion, a year-on-year increase of 14.6%. (RC)